Effect of a local, one time, low-dose injection of zoledronic acid on titanium implant osseointegration in ovariectomized rats.
BACKGROUND
Local application of bisphosphonates has been proven to be safer than systemic administration to promote implant fixation. The objective of this study was to introduce such a simple, convenient and efficient method to enhance titanium (Ti) implant osseointegration in ovariectomized (OVX) rats.


METHODS
Twenty female Sprague-Dawley rats sequentially underwent bilateral ovariectomy and tibia implantation, and injection of 30 µg/implant zoledronic acid (ZOL) at the site of implantation was performed. At the end of the study, the tibiae, mandibles, femurs and vertebrae were harvested for dual energy X-ray absorptiometry, histology and micro-computed tomography examination.


RESULTS
Ovariectomized rats showed poor bone density, bone mass and trabecular microstructure. OVX + ZOL rats were characterized by significantly improved peri-implant bone area (1.72-fold), bone contact (2.30-fold), bone mineral density (1.57-fold) and bone mineral content (1.67-fold), as well as moderately increased bone volume to total volume ratio (1.34-fold), percentage osteointegration (1.54-fold), connectivity density (1.45-fold), and trabecular number (1.43-fold), but decreased trabecular separation (57.69%) when compared with the control levels (p< 0.05). No histological signs of jaw osteonecrosis were observed in the rats treated with ZOL, and there was no significant difference between the OVX group and OVX + ZOL group in the bone mass of the mandible, femur and 5thlumbar vertebra (p> 0.05). In addition, the overproduction of osteoporosis-induced advanced glycation end-products (AGEs) was completely prevented by local treatment with 30 µg/implant ZOL.


CONCLUSIONS
A local, one time, low-dose injection of ZOL at the site of implantation is able to promote the osseointegration of Ti implants following postmenopausal osteoporosis, and this action may be partly mediated by inhibition of the osteoporosis-induced AGE overproduction in the bone marrow.
Department of Stomatology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Gao
G
Ying
Department of Stomatology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Lian
L
Bo
Department of Stomatology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Jiao
J
Yanjun
Department of Stomatology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Wu
W
Lina
Department of Stomatology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Wang
W
Binquan
advanced glycation end products; bisphosphonate; implant; osteoporosis
Tissue Eng. 2007 Apr;13(4):809-17
17394387
Bone. 2011 Jul;49(1):50-5
20727997
Arch Med Sci. 2011 Feb;7(1):53-60
22291733
Int J Oral Maxillofac Surg. 2013 Apr;42(4):537-43
22925444
Arch Med Sci. 2011 Jun;7(3):486-92
22295033
Bone. 2006 Aug;39(2):276-82
16617039
Biomaterials. 2009 Mar;30(9):1790-6
19135249
Biochem Biophys Res Commun. 2002 Mar 1;291(3):680-6
11855844
J Control Release. 2013 Apr 28;167(2):175-88
23395668
Curr Opin Rheumatol. 2010 Jul;22(4):404-9
20473174
Arch Med Sci. 2013 Aug 30;9(4):614-21
24049519
Drug Saf. 1996 Mar;14(3):158-70
8934578
Maturitas. 2013 Jun;75(2):118-24
23562167
J Periodontol. 1999 Aug;70(8):893-5
10476897
Curr Clin Pharmacol. 2013 May;8(2):124-34
23092218
Bone. 2009 Feb;44(2):225-32
19056525
Oral Dis. 2013 Nov;19(8):747-54
23346935
J Bone Miner Metab. 2008;26(6):635-41
18979164
Osteoporos Int. 2009 Jun;20(6):887-94
18850239
J Orthop Res. 2004 Mar;22(2):244-9
15013081
J Biomater Appl. 2013 Feb;27(6):727-38
22090432
Arch Med Sci. 2014 Feb 24;10(1):117-23
24701224
Eur J Pharmacol. 2008 Dec 14;600(1-3):140-7
18973752
J Control Release. 2009 Oct 1;139(1):15-21
19482052
Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):425-37
22540167
J Bone Miner Metab. 2010 Nov;28(6):601-7
20697753
J Clin Endocrinol Metab. 2010 Apr;95(4):1555-65
20173017
Acta Biomater. 2012 May;8(5):1966-75
22154860
Clin Chim Acta. 2006 Sep;371(1-2):32-6
16777084
Osteoporos Int. 2010 Oct;21(10):1723-9
19997905
J Orthop Res. 2004 Sep;22(5):1108-13
15304286
J Biomater Appl. 2012 Jul;27(1):91-8
21343217
Biochem Biophys Res Commun. 2002 Sep 20;297(2):419-24
12237136
Breast Cancer Res. 2012 Sep 21;14(5):213
23014660
Int J Tissue React. 2005;27(4):189-95
16440584
Menopause Int. 2011 Dec;17(4):137-41
22120943
Biomaterials. 2005 Dec;26(34):6941-9
16009417